CPT-11 (Irinotecan) in the treatment of colorectal cancer

This publication has 24 references indexed in Scilit:

• Comparison of Topoisomerase I Inhibition, DNA Damage, and Cytotoxicity of Camptothecin Derivatives Presently in Clinical Trials
  JNCI Journal of the National Cancer Institute, 1994
• Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1994
• DNA Topoisomerases: Essential Enzymes and Lethal Targets
  Annual Review of Pharmacology and Toxicology, 1994
• Topoisomerase I inhibitors: topotecan and irenotecan
  Cancer Treatment Reviews, 1994
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
  BMJ, 1993
• The chemotherapy of colon cancer can no longer be ignored
  European Journal Of Cancer, 1993
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.
  Journal of Clinical Oncology, 1992
• Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity
  Cancer, 1990
• Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1990